Literature DB >> 1352902

Symptomatology and electrodermal activity as predictors of neuroleptic response in young male schizophrenic inpatients.

E M Lindström1, L S Ohlund, L H Lindström, A Ohman.   

Abstract

This study examined whether the response to treatment with neuroleptic medication in 21 schizophrenic patients could be predicted from symptomatology, electrodermal activity, and premorbid adjustment. Positive symptoms and high levels of electrodermal activity were associated with a good response to conventional neuroleptic drugs. However, multivariate analysis indicated that symptomatology was the only independent predictor of treatment response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352902     DOI: 10.1016/0165-1781(92)90078-h

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability.

Authors:  R Joober; C Benkelfat; K Brisebois; A Toulouse; G Turecki; S Lal; D Bloom; A Labelle; P Lalonde; D Fortin; M Alda; R Palmour; G A Rouleau
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

2.  A subscale for negative symptoms from the Comprehensive Psychopathological Rating Scale (CPRS): a comparison with the Schedule for Assessment of Negative Symptoms (SANS).

Authors:  E Lindström; L H Lindström
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 3.  Genetics of schizophrenia: from animal models to clinical studies.

Authors:  Ridha Joober; Patricia Boksa; Chawki Benkelfat; Guy Rouleau
Journal:  J Psychiatry Neurosci       Date:  2002-09       Impact factor: 6.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.